GLATIRAMER ACETATE manufacturers
Glatiramer acetate is a medication that is the most prescribed treatment for relapsing forms of multiple sclerosis. Suppliers of glatiramer acetate medications market it as 20mg/ml and 40mg/ml powder for injectable solutions and solutions in pre-filled syringes. The developer and earliest glatiramer acetate manufacturer were Teva Pharmaceuticals, which first acquired medical approval for the drug in 1997 and began marketing it under the trade name Copaxone. It has since then become approved in over 50 countries, including but not limited to Israel, Japan, Canada, the EU countries. However, following patent expiry in 2015, other glatiramer acetate manufacturing companies have joined the market for the drug. For example, in the same year, major Swiss manufacturer Novartis introduced Glatopa, a generic substitute for Copaxone. And in late 2017, the FDA approved an additional generic version of glatiramer acetate produced by manufacturer NATCO Pharma and supplied by distributor Mylan. Although the introduction of substitutes from other manufacturing companies has hurt the sales of the Copaxone developer, it has also pushed down the price of the drug, and hence, reduced treatment costs for patients. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified glatiramer acetate manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform
Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking GLATIRAMER ACETATE: You should not use This medical drug if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide.
Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
How does GLATIRAMER ACETATE work?
The usage of this pharmaceutical substance: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking GLATIRAMER ACETATE. If you have any questions related to this medical remedy, ask your pharmacist or doctor.
It is not completely not clear how this pharmaceutical product actually works. But It appears to kill the immune cells that invade the covering (myelin) around nerves in our spinal cord and brain. It is injected under your skin once a day or, at a higher dose, 3 times a week.
Injecting this medical remedy into the fatty layer under your skin (subcutaneously). There are 7 possible areas for this medical drug Injections on your body and various injection sites within each area. Having a rotation plan helps you bypass injections in the similar sites more than once per week.
The Wholesale Price of GLATIRAMER ACETATE?
The retail prices of glatiramer acetate vary depending on whether it is a generic or trade name formulation, the concentration of the active ingredient in the formulation and supplier as well as manufacturer pricing. Costs per 28 (1ml) pre-filled syringes of 20mg/ml glatiramer acetate fall into an approximate range of 400 EUR to 600 EUR, whereas the same amount of 40mg/ml glatiramer acetate pre-filled syringes typically cost twice as much (i.e. 800 EUR to 1,200 EUR).
Sourcing the GLATIRAMER ACETATE Manufacturers and Suppliers
If you are looking to find manufacturers and suppliers of GLATIRAMER ACETATE, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures.
Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of GLATIRAMER ACETATE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of GLATIRAMER ACETATE. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where GLATIRAMER ACETATE is already registered in. Manufacturers also have special, and delivery terms.
Establishing commercial ties
If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.
To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen GLATIRAMER ACETATE manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.